Sherry Cox

Prof. Sherry Cox

Auto-generated profile, based on publicly available information

Prof. Sherry Cox


Research Focus & Metrics

Academic Career Length

36Years (1991-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 July 2008 in Veterinary Anaesthesia and Analgesia
Verified
Journal Article
Closed access
PDF file
JWJeffrey Wilson
Jeffrey Wilson
TDThomas J Doherty
Thomas J Doherty
CEChristine M Egger
Christine M Egger
AFAndrew Fidler
Andrew Fidler
SCSherry Cox
Sherry Cox
BRBarton Rohrbach
Barton Rohrbach

1 December 2009 in Journal of Avian Medicine and Surgery
Verified
Journal Article
Closed access
MSMarcy J. Souza
Marcy J. Souza
TMTomas Martin-Jimenez
Tomas Martin-Jimenez
MJMichael P. Jones
Michael P. Jones
SCSherry K. Cox
Sherry K. Cox
Analgesia is becoming increasingly important in veterinary medicine, and little research has been performed that examined pain control in avian species. Tramadol is a relatively new drug that provides analgesia by opioid (mu), serotonin, and norepinephrine pathways, with minimal adverse effects. To determine the pharmacokinetics of tramadol and its major metabolite O-desmethyltramadol (M1) in eagles, 6 bald eagles (Haliaeetus leucocephalus) were each dosed with tramadol administered intravenously (4 mg/kg) and orally (11 mg/kg) in a crossover study. Blood was collected at various time points between 0 and 600 minutes and then analyzed with high-performance liquid chromatography to determine levels of tramadol and M1, the predominate active metabolite. The terminal half-life of tramadol after intravenous dosing was 2.46 hours. The maximum plasma concentration, time of maximum plasma concentration, and terminal half life for tramadol after oral dosing were 2156.7 ng/ml, 3.75 hours, and 3.14 hours, respec vely. In addition, the oral bioavailability was 97.9%. Although plasma concentrations of ramadol and M1 associated with analgesia in any avian species is unknown, based on the obtained data and known therapeutic levels in humans, a dosage of 5 mg/kg PO q12h is recommended for bald eagles. Pharmacodynamic studies are needed to better determine plasma levels of tramadol and M1 associated with analgesia in birds.

1 March 2007 in Veterinary Anaesthesia and Analgesia
Verified
Journal Article
Closed access
PDF file
TDTom Doherty
Tom Doherty
MRMarcia A Redua
Marcia A Redua
PQPatricia Queiroz-Castro
Patricia Queiroz-Castro
CEChristine Egger
Christine Egger
SCSherry K Cox
Sherry K Cox
BRBarton W Rohrbach
Barton W Rohrbach

1 August 2008 in American Journal of Veterinary Research
Verified
Journal Article
Closed access
MSMarcy J. Souza
Marcy J. Souza
CGCheryl B. Greenacre
Cheryl B. Greenacre
SCSherry K. Cox
Sherry K. Cox
Objective—To determine the pharmacokinetics of an orally administered dose of tramadol in domestic rabbits (Oryctolagus cuniculus). Animals—6 healthy adult sexually intact female New Zealand White rabbits. Procedures—Physical examinations and plasma biochemical analyses were performed to ensure rabbits were healthy prior to the experiment. Rabbits were anesthetized with isoflurane, and IV catheters were placed in a medial saphenous or jugular vein for collection of blood samples. One blood sample was collected before treatment with tramadol. Rabbits were allowed to recover from anesthesia a minimum of 1 hour before treatment. Then, tramadol (11 mg/kg, PO) was administered once, and blood samples were collected at various time points up to 360 minutes after administration. Blood samples were analyzed with high-performance liquid chromatography to determine plasma concentrations of tramadol and its major metabolite (O-desmethyltramadol). Results—No adverse effects were detected after oral administration of tramadol to rabbits. Mean ± SD half-life of tramadol after administration was 145.4 ± 81.0 minutes; mean ± SD maximum plasma concentration was 135.3 ± 89.1 ng/mL. Conclusions and Clinical Relevance—Although the dose of tramadol required to provide analgesia in rabbits is unknown, the dose administered in the study reported here did not reach a plasma concentration of tramadol or O-desmethyltramadol that would provide sufficient analgesia in humans for clinically acceptable periods. Many factors may influence absorption of orally administered tramadol in rabbits.

1 August 2012 in American Journal of Veterinary Research
Verified
Journal Article
Closed access
DGDavid Sanchez-Migallon Guzman
David Sanchez-Migallon Guzman
MSMarcy J. Souza
Marcy J. Souza
JBJana M. Braun
Jana M. Braun
SCSherry K. Cox
Sherry K. Cox
NKNicholas S. Keuler
Nicholas S. Keuler
JPJoanne R. Paul-Murphy
Joanne R. Paul-Murphy
Objective—To evaluate antinociceptive effects on thermal thresholds after oral administration of tramadol hydrochloride to Hispaniolan Amazon parrots (Amazona ventralis). Animals—15 healthy adult Hispaniolan Amazon parrots. Procedures—2 crossover experiments were conducted. In the first experiment, 15 parrots received 3 treatments (tramadol at 2 doses [10 and 20 mg/kg] and a control suspension) administered orally. In the second experiment, 11 parrots received 2 treatments (tramadol hydrochloride [30 mg/kg] and a control suspension) administered orally. Baseline thermal foot withdrawal threshold was measured 1 hour before drug or control suspension administration; thermal foot withdrawal threshold was measured after administration at 0.5, 1.5, 3, and 6 hours (both experiments) and also at 9 hours (second experiment only). Results—For the first experiment, there were no overall effects of treatment, hour, period, or any interactions. For the second experiment, there was an overall effect of treatment, with a significant difference between tramadol hydrochloride and control suspension (mean change from baseline, 2.00° and −0.09°C, respectively). There also was a significant change from baseline for tramadol hydrochloride at 0.5, 1.5, and 6 hours after administration but not at 3 or 9 hours after administration. Conclusions and Clinical Relevance—Tramadol at a dose of 30 mg/kg, PO, induced thermal antinociception in Hispaniolan Amazon parrots. This dose was necessary for induction of significant and sustained analgesic effects, with duration of action up to 6 hours. Further studies with other types of noxious stimulation, dosages, and intervals are needed to fully evaluate the analgesic effects of tramadol hydrochloride in psittacines.

1 December 2010 in Journal of Zoo and Wildlife Medicine
Verified
Journal Article
Closed access
PBPeter A. Black
Peter A. Black
SCSherry K. Cox
Sherry K. Cox
MMMichael Macek
Michael Macek
ATAnne Tieber
Anne Tieber
RJRandall E. Junge
Randall E. Junge
Tramadol is a centrally acting opiate analgesic that has not been well studied in avian species. Tramadol and its metabolites exert their effects at multiple sites, including opiate (mu, kappa, and delta), adrenergic (alpha-2), and serotonin (5HT) receptors. This multi-receptor mode of action is advantageous for avian patients because the mechanisms for analgesia have not been fully elucidated in all species. The objective of this study was to document the pharmacokinetics of tramadol and its active metabolite O-desmethyltramadol (M1) in common peafowl (Pavo cristatus). Based on results from a pilot animal, six adult peafowl (three male, three female) judged to be clinically healthy based on physical exam and routine bloodwork were selected for this study. Each bird was anesthetized for placement of a jugular catheter, and 7.5 mg/kg tramadol was administered orally via gavage tube. Blood samples were collected just prior to drug administration; at 30 min; and at 1, 2, 3, 4, 6, 8, 10, 12, 24, and 34 hr. Plasma levels of tramadol and M1 were measured and the pharmacokinetics for each drug was calculated. Although tramadol was quickly metabolized, plasma levels of M1 remained at or near human analgesic levels for 12-24 hr. Based on these data, tramadol may be a practical option as an orally administered analgesic agent in avian patients. Further studies, including antinociceptive studies, are needed.